Global Oncology Ablation Supply, Demand and Key Producers, 2026-2032
The global Oncology Ablation market size is expected to reach $ 5594 million by 2032, rising at a market growth of 10.3% CAGR during the forecast period (2026-2032).
Oncology ablation refers to a class of minimally invasive, image-guided therapeutic procedures that deliver controlled physical energy—such as radiofrequency, microwave, cryogenic, laser, or high-intensity focused ultrasound—directly to tumor tissues to induce irreversible cell death. Typically performed via percutaneous or endoluminal approaches, it integrates imaging navigation, energy delivery systems, and applicators to achieve precise and controlled treatment. With advantages including minimal invasiveness, rapid recovery, and repeatability, oncology ablation is widely used in treating solid tumors such as liver, lung, kidney, and bone metastases. It serves both as an alternative to surgery and as part of multimodal therapy. As precision medicine and minimally invasive care evolve, oncology ablation is increasingly expanding toward curative applications in early-stage cancers and long-term disease management, becoming a cornerstone of modern oncology treatment.The average gross profit margin of this product is 72%.
Driven by national cancer control initiatives and the expansion of early screening systems, oncology treatment is shifting from late-stage intervention to early precision care, creating significant opportunities for ablation procedures. Corporate disclosures and investment research indicate continuous advancements in RF, microwave, and cryo technologies, along with improvements in imaging fusion and intelligent navigation, enhancing treatment precision and safety. At the same time, hospitals’ increasing demand for minimally invasive procedures to improve efficiency and reduce hospital stays is accelerating the transition of ablation from an adjunctive option to a standardized treatment pathway.
Despite expanding applications, variability in efficacy for complex or large tumors remains a challenge, with outcomes highly dependent on operator expertise. Industry standards, procedural guidelines, and clinical pathways are still evolving, while disparities in healthcare resources across regions limit widespread adoption. Additionally, high costs of advanced equipment and consumables, along with delays in reimbursement and guideline updates, continue to constrain market penetration.
Clinical practice is shifting from surgery-centric approaches to multidisciplinary, minimally invasive treatment models, with increasing adoption of ablation in liver cancer, lung nodules, and thyroid diseases. Growing patient demand for reduced trauma, faster recovery, and improved quality of life is driving the expansion of outpatient and day-care procedures. Furthermore, the trend toward chronic disease management in oncology is increasing demand for recurrence control and long-term care, establishing a stable and sustainable clinical demand base for ablation therapies.
Upstream components include RF power modules, microwave generators, cryogenic systems, medical-grade metals, and polymer insulation materials, all critical to treatment efficacy and safety. Industry disclosures suggest that advancements in electronics manufacturing and precision engineering are enabling partial localization of key components, although high-end sensors and imaging integration systems still rely on imports. The supply chain is evolving toward integrated platforms, with upstream players expanding technological capabilities to enhance value-added and strengthen overall competitiveness.
This report studies the global Oncology Ablation demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oncology Ablation, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oncology Ablation that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oncology Ablation total market, 2021-2032, (USD Million)
Global Oncology Ablation total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Oncology Ablation total market, key domestic companies, and share, (USD Million)
Global Oncology Ablation revenue by player, revenue and market share 2021-2026, (USD Million)
Global Oncology Ablation total market by Type, CAGR, 2021-2032, (USD Million)
Global Oncology Ablation total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Oncology Ablation market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chongqing Haifu Medical, AngioDynamics, Boston Scientific, Medtronic, Yigao Medical, Haijieya, Beijing Weierfu, Micro Tech Medical, Better Medical, Vison Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Oncology Ablation market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Oncology Ablation Market, By Region:
1. How big is the global Oncology Ablation market?
2. What is the demand of the global Oncology Ablation market?
3. What is the year over year growth of the global Oncology Ablation market?
4. What is the total value of the global Oncology Ablation market?
5. Who are the Major Players in the global Oncology Ablation market?
6. What are the growth factors driving the market demand?
Oncology ablation refers to a class of minimally invasive, image-guided therapeutic procedures that deliver controlled physical energy—such as radiofrequency, microwave, cryogenic, laser, or high-intensity focused ultrasound—directly to tumor tissues to induce irreversible cell death. Typically performed via percutaneous or endoluminal approaches, it integrates imaging navigation, energy delivery systems, and applicators to achieve precise and controlled treatment. With advantages including minimal invasiveness, rapid recovery, and repeatability, oncology ablation is widely used in treating solid tumors such as liver, lung, kidney, and bone metastases. It serves both as an alternative to surgery and as part of multimodal therapy. As precision medicine and minimally invasive care evolve, oncology ablation is increasingly expanding toward curative applications in early-stage cancers and long-term disease management, becoming a cornerstone of modern oncology treatment.The average gross profit margin of this product is 72%.
Driven by national cancer control initiatives and the expansion of early screening systems, oncology treatment is shifting from late-stage intervention to early precision care, creating significant opportunities for ablation procedures. Corporate disclosures and investment research indicate continuous advancements in RF, microwave, and cryo technologies, along with improvements in imaging fusion and intelligent navigation, enhancing treatment precision and safety. At the same time, hospitals’ increasing demand for minimally invasive procedures to improve efficiency and reduce hospital stays is accelerating the transition of ablation from an adjunctive option to a standardized treatment pathway.
Despite expanding applications, variability in efficacy for complex or large tumors remains a challenge, with outcomes highly dependent on operator expertise. Industry standards, procedural guidelines, and clinical pathways are still evolving, while disparities in healthcare resources across regions limit widespread adoption. Additionally, high costs of advanced equipment and consumables, along with delays in reimbursement and guideline updates, continue to constrain market penetration.
Clinical practice is shifting from surgery-centric approaches to multidisciplinary, minimally invasive treatment models, with increasing adoption of ablation in liver cancer, lung nodules, and thyroid diseases. Growing patient demand for reduced trauma, faster recovery, and improved quality of life is driving the expansion of outpatient and day-care procedures. Furthermore, the trend toward chronic disease management in oncology is increasing demand for recurrence control and long-term care, establishing a stable and sustainable clinical demand base for ablation therapies.
Upstream components include RF power modules, microwave generators, cryogenic systems, medical-grade metals, and polymer insulation materials, all critical to treatment efficacy and safety. Industry disclosures suggest that advancements in electronics manufacturing and precision engineering are enabling partial localization of key components, although high-end sensors and imaging integration systems still rely on imports. The supply chain is evolving toward integrated platforms, with upstream players expanding technological capabilities to enhance value-added and strengthen overall competitiveness.
This report studies the global Oncology Ablation demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oncology Ablation, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oncology Ablation that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oncology Ablation total market, 2021-2032, (USD Million)
Global Oncology Ablation total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Oncology Ablation total market, key domestic companies, and share, (USD Million)
Global Oncology Ablation revenue by player, revenue and market share 2021-2026, (USD Million)
Global Oncology Ablation total market by Type, CAGR, 2021-2032, (USD Million)
Global Oncology Ablation total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Oncology Ablation market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chongqing Haifu Medical, AngioDynamics, Boston Scientific, Medtronic, Yigao Medical, Haijieya, Beijing Weierfu, Micro Tech Medical, Better Medical, Vison Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Oncology Ablation market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Oncology Ablation Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Microwave Ablation
- Radiofrequency Ablation
- Cryoablation
- High-Intensity Focused Ultrasound (HIFU)
- Others
- Thermal
- Cryogenic
- Percutaneous
- Laparoscopic
- Open
- Liver Cancer
- Lung Cancer
- Breast Cancer
- Other
- Chongqing Haifu Medical
- AngioDynamics
- Boston Scientific
- Medtronic
- Yigao Medical
- Haijieya
- Beijing Weierfu
- Micro Tech Medical
- Better Medical
- Vison Medical
- Shanghai Maide
- HealthTronics
- J &J
- EDAP TMS
- Sonacare Medical
- Misonix
1. How big is the global Oncology Ablation market?
2. What is the demand of the global Oncology Ablation market?
3. What is the year over year growth of the global Oncology Ablation market?
4. What is the total value of the global Oncology Ablation market?
5. Who are the Major Players in the global Oncology Ablation market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Oncology Ablation Introduction
1.2 World Oncology Ablation Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Oncology Ablation Total Market by Region (by Headquarter Location)
1.3.1 World Oncology Ablation Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Oncology Ablation Revenue (2021-2032)
1.3.3 China Based Company Oncology Ablation Revenue (2021-2032)
1.3.4 Europe Based Company Oncology Ablation Revenue (2021-2032)
1.3.5 Japan Based Company Oncology Ablation Revenue (2021-2032)
1.3.6 South Korea Based Company Oncology Ablation Revenue (2021-2032)
1.3.7 ASEAN Based Company Oncology Ablation Revenue (2021-2032)
1.3.8 India Based Company Oncology Ablation Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oncology Ablation Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Oncology Ablation Consumption Value (2021-2032)
2.2 World Oncology Ablation Consumption Value by Region
2.2.1 World Oncology Ablation Consumption Value by Region (2021-2026)
2.2.2 World Oncology Ablation Consumption Value Forecast by Region (2027-2032)
2.3 United States Oncology Ablation Consumption Value (2021-2032)
2.4 China Oncology Ablation Consumption Value (2021-2032)
2.5 Europe Oncology Ablation Consumption Value (2021-2032)
2.6 Japan Oncology Ablation Consumption Value (2021-2032)
2.7 South Korea Oncology Ablation Consumption Value (2021-2032)
2.8 ASEAN Oncology Ablation Consumption Value (2021-2032)
2.9 India Oncology Ablation Consumption Value (2021-2032)
3 WORLD ONCOLOGY ABLATION COMPANIES COMPETITIVE ANALYSIS
3.1 World Oncology Ablation Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Oncology Ablation Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Oncology Ablation in 2025
3.2.3 Global Concentration Ratios (CR8) for Oncology Ablation in 2025
3.3 Oncology Ablation Company Evaluation Quadrant
3.4 Oncology Ablation Market: Overall Company Footprint Analysis
3.4.1 Oncology Ablation Market: Region Footprint
3.4.2 Oncology Ablation Market: Company Product Type Footprint
3.4.3 Oncology Ablation Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Oncology Ablation Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Oncology Ablation Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Oncology Ablation Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Oncology Ablation Consumption Value Comparison
4.2.1 United States VS China: Oncology Ablation Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Oncology Ablation Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Oncology Ablation Companies and Market Share, 2021-2026
4.3.1 United States Based Oncology Ablation Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Oncology Ablation Revenue, (2021-2026)
4.4 China Based Companies Oncology Ablation Revenue and Market Share, 2021-2026
4.4.1 China Based Oncology Ablation Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Oncology Ablation Revenue, (2021-2026)
4.5 Rest of World Based Oncology Ablation Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Oncology Ablation Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Oncology Ablation Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Oncology Ablation Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Microwave Ablation
5.2.2 Radiofrequency Ablation
5.2.3 Cryoablation
5.2.4 High-Intensity Focused Ultrasound (HIFU)
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Oncology Ablation Market Size by Type (2021-2026)
5.3.2 World Oncology Ablation Market Size by Type (2027-2032)
5.3.3 World Oncology Ablation Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY ENERGY SOURCE
6.1 World Oncology Ablation Market Size Overview by Energy Source: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Energy Source
6.2.1 Thermal
6.2.2 Cryogenic
6.3 Market Segment by Energy Source
6.3.1 World Oncology Ablation Market Size by Energy Source (2021-2026)
6.3.2 World Oncology Ablation Market Size by Energy Source (2027-2032)
6.3.3 World Oncology Ablation Market Size Market Share by Energy Source (2027-2032)
7 MARKET ANALYSIS BY PROCEDURE TYPE
7.1 World Oncology Ablation Market Size Overview by Procedure Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Procedure Type
7.2.1 Percutaneous
7.2.2 Laparoscopic
7.2.3 Open
7.3 Market Segment by Procedure Type
7.3.1 World Oncology Ablation Market Size by Procedure Type (2021-2026)
7.3.2 World Oncology Ablation Market Size by Procedure Type (2027-2032)
7.3.3 World Oncology Ablation Market Size Market Share by Procedure Type (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Oncology Ablation Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Liver Cancer
8.2.2 Lung Cancer
8.2.3 Breast Cancer
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Oncology Ablation Market Size by Application (2021-2026)
8.3.2 World Oncology Ablation Market Size by Application (2027-2032)
8.3.3 World Oncology Ablation Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Chongqing Haifu Medical
9.1.1 Chongqing Haifu Medical Details
9.1.2 Chongqing Haifu Medical Major Business
9.1.3 Chongqing Haifu Medical Oncology Ablation Product and Services
9.1.4 Chongqing Haifu Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Chongqing Haifu Medical Recent Developments/Updates
9.1.6 Chongqing Haifu Medical Competitive Strengths & Weaknesses
9.2 AngioDynamics
9.2.1 AngioDynamics Details
9.2.2 AngioDynamics Major Business
9.2.3 AngioDynamics Oncology Ablation Product and Services
9.2.4 AngioDynamics Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 AngioDynamics Recent Developments/Updates
9.2.6 AngioDynamics Competitive Strengths & Weaknesses
9.3 Boston Scientific
9.3.1 Boston Scientific Details
9.3.2 Boston Scientific Major Business
9.3.3 Boston Scientific Oncology Ablation Product and Services
9.3.4 Boston Scientific Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Boston Scientific Recent Developments/Updates
9.3.6 Boston Scientific Competitive Strengths & Weaknesses
9.4 Medtronic
9.4.1 Medtronic Details
9.4.2 Medtronic Major Business
9.4.3 Medtronic Oncology Ablation Product and Services
9.4.4 Medtronic Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Medtronic Recent Developments/Updates
9.4.6 Medtronic Competitive Strengths & Weaknesses
9.5 Yigao Medical
9.5.1 Yigao Medical Details
9.5.2 Yigao Medical Major Business
9.5.3 Yigao Medical Oncology Ablation Product and Services
9.5.4 Yigao Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Yigao Medical Recent Developments/Updates
9.5.6 Yigao Medical Competitive Strengths & Weaknesses
9.6 Haijieya
9.6.1 Haijieya Details
9.6.2 Haijieya Major Business
9.6.3 Haijieya Oncology Ablation Product and Services
9.6.4 Haijieya Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Haijieya Recent Developments/Updates
9.6.6 Haijieya Competitive Strengths & Weaknesses
9.7 Beijing Weierfu
9.7.1 Beijing Weierfu Details
9.7.2 Beijing Weierfu Major Business
9.7.3 Beijing Weierfu Oncology Ablation Product and Services
9.7.4 Beijing Weierfu Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Beijing Weierfu Recent Developments/Updates
9.7.6 Beijing Weierfu Competitive Strengths & Weaknesses
9.8 Micro Tech Medical
9.8.1 Micro Tech Medical Details
9.8.2 Micro Tech Medical Major Business
9.8.3 Micro Tech Medical Oncology Ablation Product and Services
9.8.4 Micro Tech Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Micro Tech Medical Recent Developments/Updates
9.8.6 Micro Tech Medical Competitive Strengths & Weaknesses
9.9 Better Medical
9.9.1 Better Medical Details
9.9.2 Better Medical Major Business
9.9.3 Better Medical Oncology Ablation Product and Services
9.9.4 Better Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Better Medical Recent Developments/Updates
9.9.6 Better Medical Competitive Strengths & Weaknesses
9.10 Vison Medical
9.10.1 Vison Medical Details
9.10.2 Vison Medical Major Business
9.10.3 Vison Medical Oncology Ablation Product and Services
9.10.4 Vison Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Vison Medical Recent Developments/Updates
9.10.6 Vison Medical Competitive Strengths & Weaknesses
9.11 Shanghai Maide
9.11.1 Shanghai Maide Details
9.11.2 Shanghai Maide Major Business
9.11.3 Shanghai Maide Oncology Ablation Product and Services
9.11.4 Shanghai Maide Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Shanghai Maide Recent Developments/Updates
9.11.6 Shanghai Maide Competitive Strengths & Weaknesses
9.12 HealthTronics
9.12.1 HealthTronics Details
9.12.2 HealthTronics Major Business
9.12.3 HealthTronics Oncology Ablation Product and Services
9.12.4 HealthTronics Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 HealthTronics Recent Developments/Updates
9.12.6 HealthTronics Competitive Strengths & Weaknesses
9.13 J &J
9.13.1 J &J Details
9.13.2 J &J Major Business
9.13.3 J &J Oncology Ablation Product and Services
9.13.4 J &J Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 J &J Recent Developments/Updates
9.13.6 J &J Competitive Strengths & Weaknesses
9.14 EDAP TMS
9.14.1 EDAP TMS Details
9.14.2 EDAP TMS Major Business
9.14.3 EDAP TMS Oncology Ablation Product and Services
9.14.4 EDAP TMS Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 EDAP TMS Recent Developments/Updates
9.14.6 EDAP TMS Competitive Strengths & Weaknesses
9.15 Sonacare Medical
9.15.1 Sonacare Medical Details
9.15.2 Sonacare Medical Major Business
9.15.3 Sonacare Medical Oncology Ablation Product and Services
9.15.4 Sonacare Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Sonacare Medical Recent Developments/Updates
9.15.6 Sonacare Medical Competitive Strengths & Weaknesses
9.16 Misonix
9.16.1 Misonix Details
9.16.2 Misonix Major Business
9.16.3 Misonix Oncology Ablation Product and Services
9.16.4 Misonix Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Misonix Recent Developments/Updates
9.16.6 Misonix Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Oncology Ablation Industry Chain
10.2 Oncology Ablation Upstream Analysis
10.3 Oncology Ablation Midstream Analysis
10.4 Oncology Ablation Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Oncology Ablation Introduction
1.2 World Oncology Ablation Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Oncology Ablation Total Market by Region (by Headquarter Location)
1.3.1 World Oncology Ablation Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Oncology Ablation Revenue (2021-2032)
1.3.3 China Based Company Oncology Ablation Revenue (2021-2032)
1.3.4 Europe Based Company Oncology Ablation Revenue (2021-2032)
1.3.5 Japan Based Company Oncology Ablation Revenue (2021-2032)
1.3.6 South Korea Based Company Oncology Ablation Revenue (2021-2032)
1.3.7 ASEAN Based Company Oncology Ablation Revenue (2021-2032)
1.3.8 India Based Company Oncology Ablation Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oncology Ablation Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Oncology Ablation Consumption Value (2021-2032)
2.2 World Oncology Ablation Consumption Value by Region
2.2.1 World Oncology Ablation Consumption Value by Region (2021-2026)
2.2.2 World Oncology Ablation Consumption Value Forecast by Region (2027-2032)
2.3 United States Oncology Ablation Consumption Value (2021-2032)
2.4 China Oncology Ablation Consumption Value (2021-2032)
2.5 Europe Oncology Ablation Consumption Value (2021-2032)
2.6 Japan Oncology Ablation Consumption Value (2021-2032)
2.7 South Korea Oncology Ablation Consumption Value (2021-2032)
2.8 ASEAN Oncology Ablation Consumption Value (2021-2032)
2.9 India Oncology Ablation Consumption Value (2021-2032)
3 WORLD ONCOLOGY ABLATION COMPANIES COMPETITIVE ANALYSIS
3.1 World Oncology Ablation Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Oncology Ablation Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Oncology Ablation in 2025
3.2.3 Global Concentration Ratios (CR8) for Oncology Ablation in 2025
3.3 Oncology Ablation Company Evaluation Quadrant
3.4 Oncology Ablation Market: Overall Company Footprint Analysis
3.4.1 Oncology Ablation Market: Region Footprint
3.4.2 Oncology Ablation Market: Company Product Type Footprint
3.4.3 Oncology Ablation Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Oncology Ablation Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Oncology Ablation Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Oncology Ablation Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Oncology Ablation Consumption Value Comparison
4.2.1 United States VS China: Oncology Ablation Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Oncology Ablation Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Oncology Ablation Companies and Market Share, 2021-2026
4.3.1 United States Based Oncology Ablation Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Oncology Ablation Revenue, (2021-2026)
4.4 China Based Companies Oncology Ablation Revenue and Market Share, 2021-2026
4.4.1 China Based Oncology Ablation Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Oncology Ablation Revenue, (2021-2026)
4.5 Rest of World Based Oncology Ablation Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Oncology Ablation Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Oncology Ablation Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Oncology Ablation Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Microwave Ablation
5.2.2 Radiofrequency Ablation
5.2.3 Cryoablation
5.2.4 High-Intensity Focused Ultrasound (HIFU)
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Oncology Ablation Market Size by Type (2021-2026)
5.3.2 World Oncology Ablation Market Size by Type (2027-2032)
5.3.3 World Oncology Ablation Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY ENERGY SOURCE
6.1 World Oncology Ablation Market Size Overview by Energy Source: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Energy Source
6.2.1 Thermal
6.2.2 Cryogenic
6.3 Market Segment by Energy Source
6.3.1 World Oncology Ablation Market Size by Energy Source (2021-2026)
6.3.2 World Oncology Ablation Market Size by Energy Source (2027-2032)
6.3.3 World Oncology Ablation Market Size Market Share by Energy Source (2027-2032)
7 MARKET ANALYSIS BY PROCEDURE TYPE
7.1 World Oncology Ablation Market Size Overview by Procedure Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Procedure Type
7.2.1 Percutaneous
7.2.2 Laparoscopic
7.2.3 Open
7.3 Market Segment by Procedure Type
7.3.1 World Oncology Ablation Market Size by Procedure Type (2021-2026)
7.3.2 World Oncology Ablation Market Size by Procedure Type (2027-2032)
7.3.3 World Oncology Ablation Market Size Market Share by Procedure Type (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Oncology Ablation Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Liver Cancer
8.2.2 Lung Cancer
8.2.3 Breast Cancer
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Oncology Ablation Market Size by Application (2021-2026)
8.3.2 World Oncology Ablation Market Size by Application (2027-2032)
8.3.3 World Oncology Ablation Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Chongqing Haifu Medical
9.1.1 Chongqing Haifu Medical Details
9.1.2 Chongqing Haifu Medical Major Business
9.1.3 Chongqing Haifu Medical Oncology Ablation Product and Services
9.1.4 Chongqing Haifu Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Chongqing Haifu Medical Recent Developments/Updates
9.1.6 Chongqing Haifu Medical Competitive Strengths & Weaknesses
9.2 AngioDynamics
9.2.1 AngioDynamics Details
9.2.2 AngioDynamics Major Business
9.2.3 AngioDynamics Oncology Ablation Product and Services
9.2.4 AngioDynamics Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 AngioDynamics Recent Developments/Updates
9.2.6 AngioDynamics Competitive Strengths & Weaknesses
9.3 Boston Scientific
9.3.1 Boston Scientific Details
9.3.2 Boston Scientific Major Business
9.3.3 Boston Scientific Oncology Ablation Product and Services
9.3.4 Boston Scientific Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Boston Scientific Recent Developments/Updates
9.3.6 Boston Scientific Competitive Strengths & Weaknesses
9.4 Medtronic
9.4.1 Medtronic Details
9.4.2 Medtronic Major Business
9.4.3 Medtronic Oncology Ablation Product and Services
9.4.4 Medtronic Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Medtronic Recent Developments/Updates
9.4.6 Medtronic Competitive Strengths & Weaknesses
9.5 Yigao Medical
9.5.1 Yigao Medical Details
9.5.2 Yigao Medical Major Business
9.5.3 Yigao Medical Oncology Ablation Product and Services
9.5.4 Yigao Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Yigao Medical Recent Developments/Updates
9.5.6 Yigao Medical Competitive Strengths & Weaknesses
9.6 Haijieya
9.6.1 Haijieya Details
9.6.2 Haijieya Major Business
9.6.3 Haijieya Oncology Ablation Product and Services
9.6.4 Haijieya Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Haijieya Recent Developments/Updates
9.6.6 Haijieya Competitive Strengths & Weaknesses
9.7 Beijing Weierfu
9.7.1 Beijing Weierfu Details
9.7.2 Beijing Weierfu Major Business
9.7.3 Beijing Weierfu Oncology Ablation Product and Services
9.7.4 Beijing Weierfu Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Beijing Weierfu Recent Developments/Updates
9.7.6 Beijing Weierfu Competitive Strengths & Weaknesses
9.8 Micro Tech Medical
9.8.1 Micro Tech Medical Details
9.8.2 Micro Tech Medical Major Business
9.8.3 Micro Tech Medical Oncology Ablation Product and Services
9.8.4 Micro Tech Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Micro Tech Medical Recent Developments/Updates
9.8.6 Micro Tech Medical Competitive Strengths & Weaknesses
9.9 Better Medical
9.9.1 Better Medical Details
9.9.2 Better Medical Major Business
9.9.3 Better Medical Oncology Ablation Product and Services
9.9.4 Better Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Better Medical Recent Developments/Updates
9.9.6 Better Medical Competitive Strengths & Weaknesses
9.10 Vison Medical
9.10.1 Vison Medical Details
9.10.2 Vison Medical Major Business
9.10.3 Vison Medical Oncology Ablation Product and Services
9.10.4 Vison Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Vison Medical Recent Developments/Updates
9.10.6 Vison Medical Competitive Strengths & Weaknesses
9.11 Shanghai Maide
9.11.1 Shanghai Maide Details
9.11.2 Shanghai Maide Major Business
9.11.3 Shanghai Maide Oncology Ablation Product and Services
9.11.4 Shanghai Maide Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Shanghai Maide Recent Developments/Updates
9.11.6 Shanghai Maide Competitive Strengths & Weaknesses
9.12 HealthTronics
9.12.1 HealthTronics Details
9.12.2 HealthTronics Major Business
9.12.3 HealthTronics Oncology Ablation Product and Services
9.12.4 HealthTronics Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 HealthTronics Recent Developments/Updates
9.12.6 HealthTronics Competitive Strengths & Weaknesses
9.13 J &J
9.13.1 J &J Details
9.13.2 J &J Major Business
9.13.3 J &J Oncology Ablation Product and Services
9.13.4 J &J Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 J &J Recent Developments/Updates
9.13.6 J &J Competitive Strengths & Weaknesses
9.14 EDAP TMS
9.14.1 EDAP TMS Details
9.14.2 EDAP TMS Major Business
9.14.3 EDAP TMS Oncology Ablation Product and Services
9.14.4 EDAP TMS Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 EDAP TMS Recent Developments/Updates
9.14.6 EDAP TMS Competitive Strengths & Weaknesses
9.15 Sonacare Medical
9.15.1 Sonacare Medical Details
9.15.2 Sonacare Medical Major Business
9.15.3 Sonacare Medical Oncology Ablation Product and Services
9.15.4 Sonacare Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Sonacare Medical Recent Developments/Updates
9.15.6 Sonacare Medical Competitive Strengths & Weaknesses
9.16 Misonix
9.16.1 Misonix Details
9.16.2 Misonix Major Business
9.16.3 Misonix Oncology Ablation Product and Services
9.16.4 Misonix Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Misonix Recent Developments/Updates
9.16.6 Misonix Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Oncology Ablation Industry Chain
10.2 Oncology Ablation Upstream Analysis
10.3 Oncology Ablation Midstream Analysis
10.4 Oncology Ablation Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Oncology Ablation Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Oncology Ablation Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Oncology Ablation Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Oncology Ablation Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Oncology Ablation Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Oncology Ablation Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Oncology Ablation Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Oncology Ablation Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Oncology Ablation Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Oncology Ablation Players in 2025
Table 12. World Oncology Ablation Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Oncology Ablation Company Evaluation Quadrant
Table 14. Head Office of Key Oncology Ablation Players
Table 15. Oncology Ablation Market: Company Product Type Footprint
Table 16. Oncology Ablation Market: Company Product Application Footprint
Table 17. Oncology Ablation Mergers & Acquisitions Activity
Table 18. United States VS China Oncology Ablation Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Oncology Ablation Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Oncology Ablation Companies, Headquarters (States, Country)
Table 21. United States Based Companies Oncology Ablation Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Oncology Ablation Revenue Market Share (2021-2026)
Table 23. China Based Oncology Ablation Companies, Headquarters (Province, Country)
Table 24. China Based Companies Oncology Ablation Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Oncology Ablation Revenue Market Share (2021-2026)
Table 26. Rest of World Based Oncology Ablation Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Oncology Ablation Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Oncology Ablation Revenue Market Share (2021-2026)
Table 29. World Oncology Ablation Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Oncology Ablation Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Oncology Ablation Market Size by Type (2027-2032) & (USD Million)
Table 32. World Oncology Ablation Market Size by Energy Source, (USD Million), 2021 & 2025 & 2032
Table 33. World Oncology Ablation Market Size Value by Energy Source (2021-2026) & (USD Million)
Table 34. World Oncology Ablation Market Size by Energy Source (2027-2032) & (USD Million)
Table 35. World Oncology Ablation Market Size by Procedure Type, (USD Million), 2021 & 2025 & 2032
Table 36. World Oncology Ablation Market Size Value by Procedure Type (2021-2026) & (USD Million)
Table 37. World Oncology Ablation Market Size by Procedure Type (2027-2032) & (USD Million)
Table 38. World Oncology Ablation Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Oncology Ablation Market Size by Application (2021-2026) & (USD Million)
Table 40. World Oncology Ablation Market Size by Application (2027-2032) & (USD Million)
Table 41. Chongqing Haifu Medical Basic Information, Manufacturing Base and Competitors
Table 42. Chongqing Haifu Medical Major Business
Table 43. Chongqing Haifu Medical Oncology Ablation Product and Services
Table 44. Chongqing Haifu Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Chongqing Haifu Medical Recent Developments/Updates
Table 46. Chongqing Haifu Medical Competitive Strengths & Weaknesses
Table 47. AngioDynamics Basic Information, Manufacturing Base and Competitors
Table 48. AngioDynamics Major Business
Table 49. AngioDynamics Oncology Ablation Product and Services
Table 50. AngioDynamics Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. AngioDynamics Recent Developments/Updates
Table 52. AngioDynamics Competitive Strengths & Weaknesses
Table 53. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 54. Boston Scientific Major Business
Table 55. Boston Scientific Oncology Ablation Product and Services
Table 56. Boston Scientific Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Boston Scientific Recent Developments/Updates
Table 58. Boston Scientific Competitive Strengths & Weaknesses
Table 59. Medtronic Basic Information, Manufacturing Base and Competitors
Table 60. Medtronic Major Business
Table 61. Medtronic Oncology Ablation Product and Services
Table 62. Medtronic Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Medtronic Recent Developments/Updates
Table 64. Medtronic Competitive Strengths & Weaknesses
Table 65. Yigao Medical Basic Information, Manufacturing Base and Competitors
Table 66. Yigao Medical Major Business
Table 67. Yigao Medical Oncology Ablation Product and Services
Table 68. Yigao Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Yigao Medical Recent Developments/Updates
Table 70. Yigao Medical Competitive Strengths & Weaknesses
Table 71. Haijieya Basic Information, Manufacturing Base and Competitors
Table 72. Haijieya Major Business
Table 73. Haijieya Oncology Ablation Product and Services
Table 74. Haijieya Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Haijieya Recent Developments/Updates
Table 76. Haijieya Competitive Strengths & Weaknesses
Table 77. Beijing Weierfu Basic Information, Manufacturing Base and Competitors
Table 78. Beijing Weierfu Major Business
Table 79. Beijing Weierfu Oncology Ablation Product and Services
Table 80. Beijing Weierfu Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Beijing Weierfu Recent Developments/Updates
Table 82. Beijing Weierfu Competitive Strengths & Weaknesses
Table 83. Micro Tech Medical Basic Information, Manufacturing Base and Competitors
Table 84. Micro Tech Medical Major Business
Table 85. Micro Tech Medical Oncology Ablation Product and Services
Table 86. Micro Tech Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Micro Tech Medical Recent Developments/Updates
Table 88. Micro Tech Medical Competitive Strengths & Weaknesses
Table 89. Better Medical Basic Information, Manufacturing Base and Competitors
Table 90. Better Medical Major Business
Table 91. Better Medical Oncology Ablation Product and Services
Table 92. Better Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Better Medical Recent Developments/Updates
Table 94. Better Medical Competitive Strengths & Weaknesses
Table 95. Vison Medical Basic Information, Manufacturing Base and Competitors
Table 96. Vison Medical Major Business
Table 97. Vison Medical Oncology Ablation Product and Services
Table 98. Vison Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Vison Medical Recent Developments/Updates
Table 100. Vison Medical Competitive Strengths & Weaknesses
Table 101. Shanghai Maide Basic Information, Manufacturing Base and Competitors
Table 102. Shanghai Maide Major Business
Table 103. Shanghai Maide Oncology Ablation Product and Services
Table 104. Shanghai Maide Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Shanghai Maide Recent Developments/Updates
Table 106. Shanghai Maide Competitive Strengths & Weaknesses
Table 107. HealthTronics Basic Information, Manufacturing Base and Competitors
Table 108. HealthTronics Major Business
Table 109. HealthTronics Oncology Ablation Product and Services
Table 110. HealthTronics Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. HealthTronics Recent Developments/Updates
Table 112. HealthTronics Competitive Strengths & Weaknesses
Table 113. J &J Basic Information, Manufacturing Base and Competitors
Table 114. J &J Major Business
Table 115. J &J Oncology Ablation Product and Services
Table 116. J &J Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. J &J Recent Developments/Updates
Table 118. J &J Competitive Strengths & Weaknesses
Table 119. EDAP TMS Basic Information, Manufacturing Base and Competitors
Table 120. EDAP TMS Major Business
Table 121. EDAP TMS Oncology Ablation Product and Services
Table 122. EDAP TMS Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. EDAP TMS Recent Developments/Updates
Table 124. EDAP TMS Competitive Strengths & Weaknesses
Table 125. Sonacare Medical Basic Information, Manufacturing Base and Competitors
Table 126. Sonacare Medical Major Business
Table 127. Sonacare Medical Oncology Ablation Product and Services
Table 128. Sonacare Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Sonacare Medical Recent Developments/Updates
Table 130. Sonacare Medical Competitive Strengths & Weaknesses
Table 131. Misonix Basic Information, Manufacturing Base and Competitors
Table 132. Misonix Major Business
Table 133. Misonix Oncology Ablation Product and Services
Table 134. Misonix Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Misonix Recent Developments/Updates
Table 136. Misonix Competitive Strengths & Weaknesses
Table 137. Global Key Players of Oncology Ablation Upstream (Raw Materials)
Table 138. Global Oncology Ablation Typical Customers
Table 1. World Oncology Ablation Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Oncology Ablation Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Oncology Ablation Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Oncology Ablation Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Oncology Ablation Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Oncology Ablation Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Oncology Ablation Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Oncology Ablation Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Oncology Ablation Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Oncology Ablation Players in 2025
Table 12. World Oncology Ablation Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Oncology Ablation Company Evaluation Quadrant
Table 14. Head Office of Key Oncology Ablation Players
Table 15. Oncology Ablation Market: Company Product Type Footprint
Table 16. Oncology Ablation Market: Company Product Application Footprint
Table 17. Oncology Ablation Mergers & Acquisitions Activity
Table 18. United States VS China Oncology Ablation Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Oncology Ablation Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Oncology Ablation Companies, Headquarters (States, Country)
Table 21. United States Based Companies Oncology Ablation Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Oncology Ablation Revenue Market Share (2021-2026)
Table 23. China Based Oncology Ablation Companies, Headquarters (Province, Country)
Table 24. China Based Companies Oncology Ablation Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Oncology Ablation Revenue Market Share (2021-2026)
Table 26. Rest of World Based Oncology Ablation Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Oncology Ablation Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Oncology Ablation Revenue Market Share (2021-2026)
Table 29. World Oncology Ablation Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Oncology Ablation Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Oncology Ablation Market Size by Type (2027-2032) & (USD Million)
Table 32. World Oncology Ablation Market Size by Energy Source, (USD Million), 2021 & 2025 & 2032
Table 33. World Oncology Ablation Market Size Value by Energy Source (2021-2026) & (USD Million)
Table 34. World Oncology Ablation Market Size by Energy Source (2027-2032) & (USD Million)
Table 35. World Oncology Ablation Market Size by Procedure Type, (USD Million), 2021 & 2025 & 2032
Table 36. World Oncology Ablation Market Size Value by Procedure Type (2021-2026) & (USD Million)
Table 37. World Oncology Ablation Market Size by Procedure Type (2027-2032) & (USD Million)
Table 38. World Oncology Ablation Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Oncology Ablation Market Size by Application (2021-2026) & (USD Million)
Table 40. World Oncology Ablation Market Size by Application (2027-2032) & (USD Million)
Table 41. Chongqing Haifu Medical Basic Information, Manufacturing Base and Competitors
Table 42. Chongqing Haifu Medical Major Business
Table 43. Chongqing Haifu Medical Oncology Ablation Product and Services
Table 44. Chongqing Haifu Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Chongqing Haifu Medical Recent Developments/Updates
Table 46. Chongqing Haifu Medical Competitive Strengths & Weaknesses
Table 47. AngioDynamics Basic Information, Manufacturing Base and Competitors
Table 48. AngioDynamics Major Business
Table 49. AngioDynamics Oncology Ablation Product and Services
Table 50. AngioDynamics Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. AngioDynamics Recent Developments/Updates
Table 52. AngioDynamics Competitive Strengths & Weaknesses
Table 53. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 54. Boston Scientific Major Business
Table 55. Boston Scientific Oncology Ablation Product and Services
Table 56. Boston Scientific Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Boston Scientific Recent Developments/Updates
Table 58. Boston Scientific Competitive Strengths & Weaknesses
Table 59. Medtronic Basic Information, Manufacturing Base and Competitors
Table 60. Medtronic Major Business
Table 61. Medtronic Oncology Ablation Product and Services
Table 62. Medtronic Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Medtronic Recent Developments/Updates
Table 64. Medtronic Competitive Strengths & Weaknesses
Table 65. Yigao Medical Basic Information, Manufacturing Base and Competitors
Table 66. Yigao Medical Major Business
Table 67. Yigao Medical Oncology Ablation Product and Services
Table 68. Yigao Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Yigao Medical Recent Developments/Updates
Table 70. Yigao Medical Competitive Strengths & Weaknesses
Table 71. Haijieya Basic Information, Manufacturing Base and Competitors
Table 72. Haijieya Major Business
Table 73. Haijieya Oncology Ablation Product and Services
Table 74. Haijieya Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Haijieya Recent Developments/Updates
Table 76. Haijieya Competitive Strengths & Weaknesses
Table 77. Beijing Weierfu Basic Information, Manufacturing Base and Competitors
Table 78. Beijing Weierfu Major Business
Table 79. Beijing Weierfu Oncology Ablation Product and Services
Table 80. Beijing Weierfu Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Beijing Weierfu Recent Developments/Updates
Table 82. Beijing Weierfu Competitive Strengths & Weaknesses
Table 83. Micro Tech Medical Basic Information, Manufacturing Base and Competitors
Table 84. Micro Tech Medical Major Business
Table 85. Micro Tech Medical Oncology Ablation Product and Services
Table 86. Micro Tech Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Micro Tech Medical Recent Developments/Updates
Table 88. Micro Tech Medical Competitive Strengths & Weaknesses
Table 89. Better Medical Basic Information, Manufacturing Base and Competitors
Table 90. Better Medical Major Business
Table 91. Better Medical Oncology Ablation Product and Services
Table 92. Better Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Better Medical Recent Developments/Updates
Table 94. Better Medical Competitive Strengths & Weaknesses
Table 95. Vison Medical Basic Information, Manufacturing Base and Competitors
Table 96. Vison Medical Major Business
Table 97. Vison Medical Oncology Ablation Product and Services
Table 98. Vison Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Vison Medical Recent Developments/Updates
Table 100. Vison Medical Competitive Strengths & Weaknesses
Table 101. Shanghai Maide Basic Information, Manufacturing Base and Competitors
Table 102. Shanghai Maide Major Business
Table 103. Shanghai Maide Oncology Ablation Product and Services
Table 104. Shanghai Maide Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Shanghai Maide Recent Developments/Updates
Table 106. Shanghai Maide Competitive Strengths & Weaknesses
Table 107. HealthTronics Basic Information, Manufacturing Base and Competitors
Table 108. HealthTronics Major Business
Table 109. HealthTronics Oncology Ablation Product and Services
Table 110. HealthTronics Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. HealthTronics Recent Developments/Updates
Table 112. HealthTronics Competitive Strengths & Weaknesses
Table 113. J &J Basic Information, Manufacturing Base and Competitors
Table 114. J &J Major Business
Table 115. J &J Oncology Ablation Product and Services
Table 116. J &J Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. J &J Recent Developments/Updates
Table 118. J &J Competitive Strengths & Weaknesses
Table 119. EDAP TMS Basic Information, Manufacturing Base and Competitors
Table 120. EDAP TMS Major Business
Table 121. EDAP TMS Oncology Ablation Product and Services
Table 122. EDAP TMS Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. EDAP TMS Recent Developments/Updates
Table 124. EDAP TMS Competitive Strengths & Weaknesses
Table 125. Sonacare Medical Basic Information, Manufacturing Base and Competitors
Table 126. Sonacare Medical Major Business
Table 127. Sonacare Medical Oncology Ablation Product and Services
Table 128. Sonacare Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Sonacare Medical Recent Developments/Updates
Table 130. Sonacare Medical Competitive Strengths & Weaknesses
Table 131. Misonix Basic Information, Manufacturing Base and Competitors
Table 132. Misonix Major Business
Table 133. Misonix Oncology Ablation Product and Services
Table 134. Misonix Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Misonix Recent Developments/Updates
Table 136. Misonix Competitive Strengths & Weaknesses
Table 137. Global Key Players of Oncology Ablation Upstream (Raw Materials)
Table 138. Global Oncology Ablation Typical Customers
LIST OF FIGURES
Figure 1. Oncology Ablation Picture
Figure 2. World Oncology Ablation Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Oncology Ablation Total Revenue (2021-2032) & (USD Million)
Figure 4. World Oncology Ablation Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Oncology Ablation Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Oncology Ablation Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Oncology Ablation Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Oncology Ablation Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Oncology Ablation Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Oncology Ablation Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Oncology Ablation Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Oncology Ablation Revenue (2021-2032) & (USD Million)
Figure 13. Oncology Ablation Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 16. World Oncology Ablation Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 18. China Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 23. India Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Oncology Ablation by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Oncology Ablation Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Oncology Ablation Markets in 2025
Figure 27. United States VS China: Oncology Ablation Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Oncology Ablation Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Oncology Ablation Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Oncology Ablation Market Size Market Share by Type in 2025
Figure 31. Microwave Ablation
Figure 32. Radiofrequency Ablation
Figure 33. Cryoablation
Figure 34. High-Intensity Focused Ultrasound (HIFU)
Figure 35. Others
Figure 36. World Oncology Ablation Market Size Market Share by Type (2021-2032)
Figure 37. World Oncology Ablation Market Size by Energy Source, (USD Million), 2021 & 2025 & 2032
Figure 38. World Oncology Ablation Market Size Market Share by Energy Source in 2025
Figure 39. Thermal
Figure 40. Cryogenic
Figure 41. World Oncology Ablation Market Size Market Share by Energy Source (2021-2032)
Figure 42. World Oncology Ablation Market Size by Procedure Type, (USD Million), 2021 & 2025 & 2032
Figure 43. World Oncology Ablation Market Size Market Share by Procedure Type in 2025
Figure 44. Percutaneous
Figure 45. Laparoscopic
Figure 46. Open
Figure 47. World Oncology Ablation Market Size Market Share by Procedure Type (2021-2032)
Figure 48. World Oncology Ablation Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Oncology Ablation Market Size Market Share by Application in 2025
Figure 50. Liver Cancer
Figure 51. Lung Cancer
Figure 52. Breast Cancer
Figure 53. Other
Figure 54. World Oncology Ablation Market Size Market Share by Application (2021-2032)
Figure 55. Oncology Ablation Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. Oncology Ablation Picture
Figure 2. World Oncology Ablation Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Oncology Ablation Total Revenue (2021-2032) & (USD Million)
Figure 4. World Oncology Ablation Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Oncology Ablation Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Oncology Ablation Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Oncology Ablation Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Oncology Ablation Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Oncology Ablation Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Oncology Ablation Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Oncology Ablation Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Oncology Ablation Revenue (2021-2032) & (USD Million)
Figure 13. Oncology Ablation Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 16. World Oncology Ablation Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 18. China Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 23. India Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Oncology Ablation by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Oncology Ablation Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Oncology Ablation Markets in 2025
Figure 27. United States VS China: Oncology Ablation Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Oncology Ablation Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Oncology Ablation Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Oncology Ablation Market Size Market Share by Type in 2025
Figure 31. Microwave Ablation
Figure 32. Radiofrequency Ablation
Figure 33. Cryoablation
Figure 34. High-Intensity Focused Ultrasound (HIFU)
Figure 35. Others
Figure 36. World Oncology Ablation Market Size Market Share by Type (2021-2032)
Figure 37. World Oncology Ablation Market Size by Energy Source, (USD Million), 2021 & 2025 & 2032
Figure 38. World Oncology Ablation Market Size Market Share by Energy Source in 2025
Figure 39. Thermal
Figure 40. Cryogenic
Figure 41. World Oncology Ablation Market Size Market Share by Energy Source (2021-2032)
Figure 42. World Oncology Ablation Market Size by Procedure Type, (USD Million), 2021 & 2025 & 2032
Figure 43. World Oncology Ablation Market Size Market Share by Procedure Type in 2025
Figure 44. Percutaneous
Figure 45. Laparoscopic
Figure 46. Open
Figure 47. World Oncology Ablation Market Size Market Share by Procedure Type (2021-2032)
Figure 48. World Oncology Ablation Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Oncology Ablation Market Size Market Share by Application in 2025
Figure 50. Liver Cancer
Figure 51. Lung Cancer
Figure 52. Breast Cancer
Figure 53. Other
Figure 54. World Oncology Ablation Market Size Market Share by Application (2021-2032)
Figure 55. Oncology Ablation Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
